Clinical Chemistry Analyzer Provides DAU Screening

No hardware or software updates are required, and the added functionality will benefit both current owners and new customers.

EasyRA clinical chemistry analyzer is a fully automated clinical chemistry analyzer that accommodates the diverse needs of small laboratories. The decision to expand the EasyRA’s capabilities into DAU was driven by the call of laboratory and healthcare professionals for a moderately complex, benchtop clinical chemistry analyzer that can also provide urine drug screening.

The EasyRA clinical chemistry system combines moderately complex drugs of abuse and routine chemistry on a single, easy-to-use, moderately complex benchtop analyzer. The EasyRA will offer a panel of drugs of abuse with simply interpreted positive or negative results, to eliminate the need for subjective interpretation in the moderately complex setting. The reagents to enable the new assays are immediately available from Medica’s distribution partners.

Robert Hagopian, BSc, JD, the President, and CEO, Medica Corporation, sad, “Patients and providers will benefit from accurate and cost-effective results when providing pain management treatment, and for applications requiring drugs of abuse screening. This combination of chemistry and DAU screening ability will uniquely position EasyRA users to provide more, faster, and more cost-effective analysis than before. With this announcement, we are continuing to fulfill our commitment to deliver the latest product updates in one convenient installation.” Medica will debut and demonstrate the EasyRA analyzer’s new capability at the annual scientific meeting of the American Association for Clinical Chemistry (AACC), held August 1-3, 2017, in San Diego, CA, USA.

Related Links:
Medica Corporation